Company: G
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001398659-25-000059
Chunk: 71

Company: Genpact LTD
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 71
---
62,061 $47,003 Consumer and Healthcare186,198 217,175 403,373 262,148 74,429 66,796 High Tech and Manufacturing195,851 225,545 421,396 275,207 77,143 69,046 Net revenues$523,835 $607,402 $1,131,237 Unallocated corporate expenses966 (966)Stock-based compensation expense(9,181)Amortization and impairment of acquired intangible assets (other than included above)(6,925)Foreign exchange gains, net837 Interest income (expense), net(10,242)Income tax expense(39,421)Net income116,947 *Other segment items primarily includes selling, general and administrative expenses (excluding stock-based compensation expenses), other operating (income) expense, net and other income (expense), net.

37

GENPACT LIMITED AND ITS SUBSIDIARIESNotes to the Consolidated Financial Statements(Unaudited)(In thousands, except per share data and share count)

17. Segment reporting (Continued)Revenues, cost of revenue, other segment items and adjusted income from operations for each of the Company’s segments for the three months ended March 31, 2025 were as follows:  Net revenuesData-Tech-AIDigital operationsTotalCost of RevenueOther segment items*AOIFinancial Services166,511 160,709 327,220 $206,838 $62,190 58,192 Consumer and Healthcare197,578 222,906 420,484 273,630 76,530 70,324 High Tech and Manufacturing217,859 249,363 467,222 305,464 81,643 80,115 Net revenues581,948 632,978 1,214,926 Unallocated corporate expenses(1,103)1,103 Stock-based compensation(20,036)Amortization and impairment of acquired intangible assets (other than included above)(4,318)Foreign exchange gains, net1,289 Interest income (expense), net(11,446)Income tax expense(44,370)Net income130,853 

*Other segment items primarily includes selling, general and administrative expenses (excluding stock-based compensation expenses), other operating (income) expense, net and other income (expense), net.        

38

GENPACT LIMITED AND ITS SUBS